Literature DB >> 11368586

Changes in essential oil during enzyme-assisted ensiling of lemongrass (Cymbopogon citratus Stapf.) and lemon eucalyptus (Eucalyptus citriodora Hook).

N Dudai1, Z G Weinberg, O Larkov, U Ravid, G Ashbell, E Putievsky.   

Abstract

Changes in essential oil during ensiling of lemongrass and lemon eucalyptus were studied. Wilted lemongrass and eucalyptus leaves were ensiled in 0.25-L anaerobic jars. Samples consisted of a control (no additives) and a treated sample (0.5% glucose and lactic acid bacteria and 1% cellulase plus 1% hemicellulase plus pectinase). Three jars per treatment were sampled on days 2, 6, 10, and 36 for analysis of essential oil. Essential oil was obtained by extraction and by hydrodistillation. Extraction efficacy of essential oil from the lemongrass was improved by the enzyme treatment, but it was much lower than the amount obtained by distillation. The major components of the essential oil were neral and geranial. In the eucalyptus, total essential oils obtained by distillation decreased during ensiling, and the amount was similar to the amount obtained by extraction. Citronellal, which was the major component of the essential oil in the fresh eucalyptus leaves, decreased, whereas isopulegol and 3,8-terpinolhydrate increased during ensiling.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11368586     DOI: 10.1021/jf001324+

Source DB:  PubMed          Journal:  J Agric Food Chem        ISSN: 0021-8561            Impact factor:   5.279


  2 in total

1.  Biotransformation of 1,8-cineole by solid-state fermentation of Eucalyptus waste from the essential oil industry using Pleurotus ostreatus and Favolus tenuiculus.

Authors:  Alejandra Omarini; José Sebastián Dambolena; Enrique Lucini; Santiago Jaramillo Mejía; Edgardo Albertó; Julio A Zygadlo
Journal:  Folia Microbiol (Praha)       Date:  2015-09-06       Impact factor: 2.099

2.  Isolation of Bioactive Compounds That Relate to the Anti-Platelet Activity of Cymbopogon ambiguus.

Authors:  I Darren Grice; Kelly L Rogers; Lyn R Griffiths
Journal:  Evid Based Complement Alternat Med       Date:  2011-02-14       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.